Aytu Biopharma (AYTU) Interest & Investment Income (2019 - 2020)

Aytu Biopharma (AYTU) reported Interest & Investment Income of -$378958.0 for Q4 2020, up 15.21% year-over-year from -$328916.7 in Q1 2020, and up 29.67% quarter-over-quarter from -$538862.0 in Q1 2020.

Aytu Biopharma (AYTU) Interest & Investment Income (2019 - 2020) Analysis & Trends

Aytu Biopharma (AYTU) has 2 years of Interest & Investment Income data on file, last reported at -$378958.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 41.80 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 28.10 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 8.54 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 4.97 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Aytu Biopharma 23.76 Mn -2.96 Mn 7.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 -378,958.00
Mar 31, 2020 -538,862.00
Dec 31, 2019 -446,958.00